ORAGENICS, INC. (OGEN) Operating cash flow 2016–2025
ORAGENICS, INC. (OGEN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$9.2MFY2025 · since FY2016: -$7.1M → -$9.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.2M | -7.5% |
| FY2024 | -$8.6M | -17.9% |
| FY2023 | -$7.3M | +52.1% |
| FY2022 | -$15.2M | -13.1% |
| FY2021 | -$13.5M | +20.5% |
| FY2020 | -$17.0M | -30.3% |
| FY2019 | -$13.0M | -43.3% |
| FY2018 | -$9.1M | -42.7% |
| FY2017 | -$6.4M | +10.1% |
| FY2016 | -$7.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OGEN financial trends
OGEN RevenueOGEN Net incomeOGEN Net marginOGEN Gross profitOGEN Gross marginOGEN Operating incomeOGEN Operating marginOGEN Free cash flowOGEN Capital expendituresOGEN Return on equityOGEN Stock buybacksOGEN Dividends paidOGEN Total assetsOGEN Total liabilitiesOGEN Shareholders’ equityOGEN overview →